Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT05952622
Other study ID # CPM
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date April 1, 2018
Est. completion date December 31, 2023

Study information

Verified date July 2023
Source Technische Universität Dresden
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Patients suffering from a proximal humerus fracture treated with plate osteosynthesis will receive either regular aftercare (physiotherapy) or aftercare assisted with continous passive motion (physiotherapy + CPM). Change in functional and patient-reported outcome (PROM) over time will be evaluated and compared.


Description:

The investigators will conduct a prospective, monocentric study focusing on the rehabilitation process after surgical treatment of proximal humerus fractures. Patients treated with plate osteosynthesis and eligible to participate will be randomly assigend to either a regular rehabilitation protocol (immobilization and physiotherapy) or a rehabilitation protocol with the additional use of a continous passive motion device (immobilization, physiotherapy and CPM). After 6 and 12 weeks as well as 1 year in a follow-up examination functional (range of motion) and patient-reported outcome (Disabilities of Arm, Shoulder and Hand Score [DASH], Constant-Score, pain on visual analogue scale, subjective satisfaction) will be evaluated. Results will be compared towards possible differences and effect of CPM therapy. In addition demographic factors (age, sex, BMI, etc.) and complications will be analysed.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 103
Est. completion date December 31, 2023
Est. primary completion date February 28, 2022
Accepts healthy volunteers No
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: - patients with proximal humeral fracture treated with plate osteosynthesis during the enrollment period - understanding of German language (written and oral) - written informed consent of the patient or the legal guardian Exclusion Criteria: - patients not meeting the aforementioned criteria - patients with the need of / or an already existing endoprosthesis - patients with ipsilateral fracture of the distal radius - patients with cerebral damage (contusio or commotio cerebri) - patients with affection of the brachial plexus or nerve palsy - non-compliance

Study Design


Intervention

Device:
Continuous passive motion therapy
Patients will be supplied with a continuous passive motion device which will allow additional individual treatment of the affected shoulder for 6 weeks.

Locations

Country Name City State
Germany University Center of Orthopaedics and Traumatology, University Medicine Carl Gustav Carus Dresden, TU Dresden Dresden Saxonia

Sponsors (1)

Lead Sponsor Collaborator
Technische Universität Dresden

Country where clinical trial is conducted

Germany, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in Range of Motion (ROM) after 6 weeks, 12 weeks and 1 year Objetive functional clinical result. Evaluation ot Motion of the shoulder in ° measured via goniometer. Physiological Abduction/Adduction: 180/0/40°, Anteversion/Retroversion 160/0/40°, external/internal rotation: 70/0/60° Time of Follow-Up assesment, 6 and 12weeks as well as 1year after surgical treatment
Primary Change of Disabilities of Arm, Shoulder and Hand Score (DASH) after 6 weeks, 12 weeks and 1 year Evaluation of the subjective function (patient reported outcome) using the DASH-Score, 0-100, best: 0, worst: 100 Time of Follow-Up assesment, 6 and 12weeks as well as 1year after surgical treatment
Primary Change of Constant-Score (CSS) after 6 weeks, 12 weeks and 1 year Evaluation of the subjective function (patient reported outcome) using the Constant-Score, 0-100, best: 100, worst: 0 Time of Follow-Up assesment, 6 and 12weeks as well as 1year after surgical treatment
Primary Change of Pain on visual analogue scale (VAS) after 6 weeks, 12 weeks and 1 year Evaluation of the subjective pain using a visual analogue scale, 0-10, best:0, worst: 10 Time of Follow-Up assesment, 6 and 12weeks as well as 1year after surgical treatment
Primary Change of Subjective satisfaction with surgical treatment (SSV) after 6 weeks, 12 weeks and 1 year Evaluation of the subjective satisfaction using the subjective shoulder value, 0-100, best:100, worst: 0 Time of Follow-Up assesment, 6 and 12weeks as well as 1year after surgical treatment
Secondary Influence of demographic factors upon rehabilitation process Evaluation of the underlying demographic factors (gender, age, BMI) and whether these affect the functional and patient-reported outcome (univariate regressional analysis) Time of Follow-Up assesment, 6 and 12weeks as well as 1year after surgical treatment
See also
  Status Clinical Trial Phase
Terminated NCT02362100 - Proximal Humerus Fractures Randomized Control Trial N/A
Recruiting NCT04106674 - Two- Part Proximal Humerus - Conservative vs Operative N/A
Recruiting NCT05943574 - PMCF Study on the Safety, Performance and Clinical Benefits Data of the XtraFix® Small External Fixation System
Recruiting NCT03060876 - Hanover Humerus Registry N/A
Completed NCT03646253 - Analysis of Four-fragment Fractures of the Proximal Humerus: the Interest of 2D and 3D Imagery and Inter- and Intra-observer Reproducibility
Recruiting NCT05351112 - PMCF Study on the Safety, Performance and Clinical Benefits Data of the Anatomical Shoulder 2.0 Fracture System
Not yet recruiting NCT04572022 - Impact of Mobile Health Technology Application on Proximal Humerus Fracture Care Practice N/A